Targeting a Membrane Protease that Controls NK Cell Maturation
靶向控制 NK 细胞成熟的膜蛋白酶
基本信息
- 批准号:10506509
- 负责人:
- 金额:$ 24.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-01 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAntiviral ResponseAspartateAspartic EndopeptidasesBindingBiologicalBiological AssayCancerousCell LineageCell MaturationCell physiologyCellsCellular AssayDefectDevelopmentDiseaseEffector CellEngineeringEventExhibitsFamilyHealthHumanITGAM geneImmuneImmune systemIn VitroKnock-in MouseKnowledgeLeukocytesLipid BilayersLymphocyteLymphocyte FunctionLymphoid CellMalignant NeoplasmsMembraneMetalloproteasesMolecularMolecular TargetMouse StrainsMusNatural Killer CellsPathway interactionsPeptide HydrolasesProcessProtein AnalysisProteinsProteolysisRoleSerine ProteaseSiteStressSubstrate InteractionT-LymphocyteTumor Cell Linearmbasecell behaviorcytotoxiccytotoxicitydesignimmune system functionin vivomutantneoplastic cellnovelnovel therapeuticspathogenpresenilinrhomboidsignal peptide peptidasetherapy designtumor
项目摘要
PROJECT SUMMARY/ABSTRACT
A variety of important biological pathways in health and disease are regulated by intramembrane proteolysis, the
process that achieves the targeted cleavage of protein substrates within or proximal to the lipid bilayer. Four
classes of intramembrane proteases have been described, including the site 2 protease (S2P) metalloprotease
family, the rhomboid serine protease family, the Rce1 glutamyl protease family, and the aspartyl protease family
that includes presenilins and the related Signal Peptide Peptidase (SPP)-like (SPPL) subfamily. The aspartyl
proteases of the SPPL subfamily, including SPP, SPPL2a, SPPL2b, SPPL2c, and SPPL3, are perhaps the least
understood subset of intramembrane proteases. Only recently have the biological roles of some of these
proteases emerged, and only a handful of relevant biological substrates have been identified. How these
intramembrane proteases specifically recognize and cleave their substrates remains mysterious. We discovered
a critical role for SPPL3 in NK cell maturation and cytotoxicity. SPPL3 is required in a cell-autonomous manner
for the maturation of NK cells from the immature CD27+CD11b- stage to the CD27+CD11b+ and CD27-CD22b+
stages, and for normal NK cell cytotoxicity toward tumor cell targets. Mice engineered to express only SPPL3
D271A in the NK lineage revealed that the proteolytic function of SPPL3 is required in NK cell maturation and
function. Like other aspartyl intramembrane proteases of the SPPL subfamily, very little is known about how
SPPL3 recognizes and cleaves its substrates. All SPPL proteases possess YD and GXGD motifs that contain
the catalytic aspartates, but other regions in the protein that are required for substrate recognition and cleavage
have not been identified. Furthermore, although some SPPL3 substrates have been identified, the relevant
substrate that must be cleaved by SPPL3 during NK cell maturation is currently unknown. To expand our basic
understanding of SPPL3 and related aspartyl intramembrane proteases, and to advance understanding of the
key checkpoint in NK cell maturation controlled by SPPL3, we will use newly developed substrate binding and
cleavage assays to define SPPL3 determinants required for substrate selection and to identify SPPL3 substrates
in NK cells. Our results will expand understanding of intramembrane aspartyl proteases and illuminate molecular
events that control NK cell development and function.
项目概要/摘要
健康和疾病中的多种重要生物途径均受到膜内蛋白水解作用的调节,
该过程实现脂质双层内或邻近脂质双层的蛋白质底物的靶向裂解。四
膜内蛋白酶的类别已被描述,包括位点 2 蛋白酶 (S2P) 金属蛋白酶
家族、菱形丝氨酸蛋白酶家族、Rce1 谷氨酰蛋白酶家族和天冬氨酰蛋白酶家族
其中包括早老素和相关的信号肽肽酶 (SPP) 样 (SPPL) 亚家族。天冬氨酰
SPPL 亚家族的蛋白酶,包括 SPP、SPPL2a、SPPL2b、SPPL2c 和 SPPL3,可能是最少的
了解膜内蛋白酶的子集。直到最近才发现其中一些的生物学作用
蛋白酶出现了,但仅鉴定了少数相关的生物底物。这些如何
膜内蛋白酶特异性识别并切割其底物仍然是个谜。我们发现
SPPL3 在 NK 细胞成熟和细胞毒性中发挥关键作用。细胞自主方式需要 SPPL3
用于 NK 细胞从未成熟的 CD27+CD11b- 阶段成熟到 CD27+CD11b+ 和 CD27-CD22b+
阶段,以及正常 NK 细胞对肿瘤细胞靶标的细胞毒性。小鼠被设计为仅表达 SPPL3
NK 谱系中的 D271A 揭示了 SPPL3 的蛋白水解功能是 NK 细胞成熟和
功能。与 SPPL 亚家族的其他天冬氨酰膜内蛋白酶一样,人们对如何实现知之甚少。
SPPL3 识别并切割其底物。所有 SPPL 蛋白酶都具有 YD 和 GXGD 基序,其中包含
催化天冬氨酸,但蛋白质中底物识别和切割所需的其他区域
尚未被识别。此外,虽然已经鉴定了一些 SPPL3 底物,但相关
NK 细胞成熟过程中必须被 SPPL3 裂解的底物目前尚不清楚。扩大我们的基础
了解 SPPL3 和相关的天冬氨酰膜内蛋白酶,并促进对
SPPL3 控制 NK 细胞成熟的关键检查点,我们将使用新开发的底物结合和
裂解测定以确定底物选择所需的 SPPL3 决定簇并鉴定 SPPL3 底物
在 NK 细胞中。我们的结果将扩大对膜内天冬氨酰蛋白酶的理解并阐明分子
控制 NK 细胞发育和功能的事件。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joel L Pomerantz其他文献
Joel L Pomerantz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joel L Pomerantz', 18)}}的其他基金
Targeting a Membrane Protease that Controls NK Cell Maturation
靶向控制 NK 细胞成熟的膜蛋白酶
- 批准号:
10631217 - 财政年份:2022
- 资助金额:
$ 24.56万 - 项目类别:
Mechanisms of Control of Lymphocyte Activation and Proliferation by a Critical Signaling Integrator
关键信号整合器控制淋巴细胞激活和增殖的机制
- 批准号:
10063977 - 财政年份:2019
- 资助金额:
$ 24.56万 - 项目类别:
Mechanisms of Control of Lymphocyte Activation and Proliferation by a Critical Signaling Integrator
关键信号整合器控制淋巴细胞激活和增殖的机制
- 批准号:
10528445 - 财政年份:2019
- 资助金额:
$ 24.56万 - 项目类别:
Mechanisms of Control of Lymphocyte Activation and Proliferation by a Critical Signaling Integrator
关键信号整合器控制淋巴细胞激活和增殖的机制
- 批准号:
10304147 - 财政年份:2019
- 资助金额:
$ 24.56万 - 项目类别:
Regulation of CARD11 signaling in normal and dysregulated lymphocyte development
CARD11 信号在正常和失调淋巴细胞发育中的调节
- 批准号:
8704412 - 财政年份:2013
- 资助金额:
$ 24.56万 - 项目类别:
Regulation of CARD11 signaling in normal and dysregulated lymphocyte development
CARD11 信号在正常和失调淋巴细胞发育中的调节
- 批准号:
9056446 - 财政年份:2013
- 资助金额:
$ 24.56万 - 项目类别:
Regulation of CARD11 signaling in normal and dysregulated lymphocyte development
CARD11 信号在正常和失调淋巴细胞发育中的调节
- 批准号:
8829795 - 财政年份:2013
- 资助金额:
$ 24.56万 - 项目类别:
Regulation of CARD11 signaling in normal and dysregulated lymphocyte development
CARD11 信号在正常和失调淋巴细胞发育中的调节
- 批准号:
8554256 - 财政年份:2013
- 资助金额:
$ 24.56万 - 项目类别:
Motor protein regulation of T cell receptor signaling
T 细胞受体信号传导的运动蛋白调节
- 批准号:
8099462 - 财政年份:2009
- 资助金额:
$ 24.56万 - 项目类别:
Motor protein regulation of T cell receptor signaling
T 细胞受体信号传导的运动蛋白调节
- 批准号:
7648345 - 财政年份:2009
- 资助金额:
$ 24.56万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 24.56万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 24.56万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 24.56万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 24.56万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 24.56万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 24.56万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 24.56万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 24.56万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 24.56万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 24.56万 - 项目类别: